137
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization

, , , , , , , , & show all
Pages 2027-2034 | Published online: 17 Jul 2019

References

  • Backhouse T, Camino J, Mioshi E. What do we know about behavioral crises in dementia? A systematic review. J Alzheimers Dis. 2018;62:99–113. doi:10.3233/JAD-17067929439334
  • Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer’s disease. Lancet. 2011;377:1019–1031. doi:10.1016/S0140-6736(10)61349-921371747
  • Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol. 2012;3:73. doi:10.3389/fneur.2012.0007322586419
  • Gilhooly KJ, Gilhooly MLM, Sullivan MP, et al. A meta-review of stress, coping and interventions in dementia and dementia caregiving. BMC Geriatr. 2016;16:106. doi:10.1186/s12877-016-0280-827193287
  • Katona C, Livingston G, Cooper C, Ames D, Brodaty H, Chiu E. International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia. Int Psychogeriatr. 2007;19:345–354. doi:10.1017/S104161020700514517386120
  • Weisman de Mamani A, Weintraub MJ, Maura J, Martinez de Andino A, Brown CA. Stigma, expressed emotion, and quality of life in caregivers of individuals with dementia. Fam Process. 2017;57:694–706. doi:10.1111/famp.1232529034464
  • Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–2314. doi:10.1212/wnl.44.12.23087991117
  • Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer’s disease: phenomenology and treatment. J Clin Psychiatry. 1987;48 Suppl:9–15.
  • Mar J, Arrospide A, Soto-Gordoa M, et al. Validity of a computerized population registry of dementia based on clinical databases. Neurologia. Epub 2018 May 8. pii: S0213-4853(18)30090–2.
  • Zhao Q-F, Tan L, Wang H-F, et al. The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: systematic review and meta-analysis. J Affect Disord. 2016;190:264–271. doi:10.1016/j.jad.2015.09.06926540080
  • Olfson M, King M, Schoenbaum M. Antipsychotic treatment of adults in the United States. J Clin Psychiatry. 2015;76(10):1346–1353. doi:10.4088/JCP.15m0986326528641
  • Stocks SJ, Kontopantelis E, Webb RT, Avery AJ, Burns A, Ashcroft DM. Antipsychotic prescribing to patients diagnosed with dementia without a diagnosis of psychosis in the context of national guidance and drug safety warnings: longitudinal study in UK general practice. Drug Saf. 2017;40:679–692. doi:10.1007/s40264-017-0538-x28439716
  • Jaakkimainen RL, Bronskill SE, Tierney MC, et al. Identification of physician-diagnosed Alzheimer’s disease and related dementias in population-based administrative data: a validation study using family physicians’ electronic medical records. J Alzheimers Dis. 2016;54:337–349. doi:10.3233/JAD-16010527567819
  • Stringhini S, Carmeli C, Jokela M, et al. Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1·7 million men and women. Lancet. 2017;389:1229–1237. doi:10.1016/S0140-6736(16)32380-728159391
  • Crombie IK, Irvine L, Elliott L, Wallace H. Closing the Health Inequalities Gap: An International Perspective. WHO Regional Office for Europe; 2005 Available from: http://www.euro.who.int/__data/assets/pdf_file/0005/124529/E87934.pdf. Accessed 73, 2019
  • Cadar D, Lassale C, Davies H, Llewellyn DJ, Batty GD, Steptoe A. Individual and area-based socioeconomic factors associated with dementia incidence in england: evidence from a 12-year follow-up in the english longitudinal study of ageing. JAMA Psychiatry. 2018;75:723–732. doi:10.1001/jamapsychiatry.2018.101229799983
  • Domínguez-Berjón MF, Borrell C, Cano-Serral G, et al. Constructing a deprivation index based on census data in large Spanish cities (the MEDEA project). Gac Sanit. 2008;22:179–187.
  • Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–2117. doi:10.1016/S0140-6736(05)67889-016360788
  • Kales HC, Maust DT. Good intentions, but what about unintended consequences? Drug Saf. 2017;40:647–649. doi:10.1007/s40264-017-0554-x28660499
  • Department of Health. Living Well with Dementia: A National Dementia Strategy. London: Department of Health; 2009.
  • Tao Y, Peters ME, Drye LT, et al. Sex differences in the neuropsychiatric symptoms of patients with Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 2018;33:450–457. doi:10.1177/153331751878327829969907
  • van Bilsen PM, Hamers JP, Don AA, Groot W, Spreeuwenberg C. The use of social services by community-dwelling older persons who are at risk of institutionalization: a survey. Eur J Ageing. 2010;7:101–109. doi:10.1007/s10433-010-0150-820730084
  • Soto-Gordoa M, Arrospide A, Zapiain A, Aiarza A, Abecia LC, Mar J. The cost of applying the dependency law to Alzheimer disease. Gac Sanit. 2014;28:389–392. doi:10.1016/j.gaceta.2014.04.01224889701
  • Oliva J, Vilaplana C, Osuna R. The social value of informal care provided to elderly dependent people in Spain. Gac Sanit. 2011;25 Suppl 2:108–114. doi:10.1016/j.gaceta.2011.09.005
  • Peña-Longobardo LM, Oliva-Moreno J. Caregiver burden in Alzheimer’s disease patients in Spain. J Alzheimers Dis. 2015;43:1293–12302. doi:10.3233/JAD-14137425159671
  • Agüera-Ortiz L, Moríñigo-Domínguez A, Olivera-Pueyo J, Pla-Vidal J, Azanza JR. Use of antipsychotics in late-life: document of the Spanish Society of Psychogeriatrics. Psicogeriatría. 2017;7(Supl 1):S1–S37.
  • Banerjee S. The Use of Antipsychotic Medication for People with Dementia: Time for Action. London, UK: Department of Health; 2009.
  • Sanfélix-Gimeno G, Cervera-Casino P, Peiró S, López-Valcarcel BG, Blázquez A, Barbera T. Effectiveness of safety warnings in atypical antipsychotic drugs: an interrupted time-series analysis in Spain. Drug Saf. 2009;32:1075–1087. doi:10.2165/11316520-000000000-0000019810779
  • Donegan K, Fox N, Black N, Livingston G, Banerjee S, Burns A. Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study. Lancet Public Health. 2017;2:e149–e156. doi:10.1016/S2468-2667(17)30031-229253388
  • Trivedi DP, Braun A, Dickinson A, et al. Managing behavioural and psychological symptoms in community dwelling older people with dementia: 1. A systematic review of the effectiveness of interventions. Dementia (London). 2018:1471301218762851. doi:10.1177/147130121876285129557183
  • Krishnamoorthy A, Anderson D. Managing challenging behaviour in older adults with dementia. Prog Neurol Psychiatry. 2011;15:20–27. doi:10.1002/pnp.199
  • Anderson G, Oderkirk J, editors. Dementia Research and Care: Can Big Data Help? Paris: OECD Publishing; 2015.
  • Banaszak-Holl J, Fendrick AM, Foster NL, et al. Predicting nursing home admission: estimates from a 7-year follow-up of a nationally representative sample of older Americans. Alzheimer Dis Assoc Disord. 2004;18:83–89.15249852